GGO Vergunningendatabase

IM-MV 17-002_000 VU medisch centrum Evaluation following the administration of autologous T cells genetically modified with a retroviral vector to express Chimeric Antigen Receptors (CAR) in subject with malignant diseases 15-01-2018 Vergunning verleend
IM-MV 17-004_000 Het Nederlands Kanker Instituut A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of the Recombinant BCG VPM1002BC in Patients with Recurrent Non-Muscle Invasive Bladder Cancer after Standard BCG Therapy 25-01-2018 Vergunning verleend
IM-MV 17-006_000 Prinses Máxima Centrum Testing CTL019 in children with B-cell malignancies Ontwerpbesluit genomen